Baumeister Baumeister SH SH Phase I trial of Autologous CAR T cells targeting NKG2D Ligands in patients with AML/MDS and multiple myeloma Phase I trial of Autologous CAR T cells targeting NKG2D Ligands in patients with AML/MDS and multiple myeloma Cancer Immunol Res Cancer Immunol Res 2019 2019 7 7 1 1 100 100 112 112 10.1158/2326-6066.CIR-18-0307 10.1158/2326-6066.CIR-18-0307 30396908 30396908. This evidence concerns the gene KLRK1 and plasma cell myeloma.